Achieve Life Sciences appoints Mark K. Oki as CFO effective December 5, 2024

ACHIEVE LIFE SCIENCES, INC.

Mark Oki previously CFO of Aytu Biopharma, Vivus LLC, Alexza Pharmaceuticals.
Base salary $450,000/year; annual discretionary bonus up to 40% of base.
Awarded option for 72,000 shares (1/3 vest year 1, then monthly) and 168,000 performance-based RSUs.
Severance: 12 months salary (24 months on change in control) plus healthcare and accelerated equity vesting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.